Omiloxetine (omiloextinum, omiloxetino INN) was a selective serotonin reuptake inhibitor drug candidate that underwent preclinical development by the Spanish pharmaceutical company, Ferrer Internacional, until 2005, when it was abandoned. Rafael Foguet also patented Abaperidone.
Omiloxetine (omiloextinum, omiloxetino INN) was a selective serotonin reuptake inhibitor drug candidate that underwent preclinical development by the Spanish pharmaceutical company, Ferrer Internacional, until 2005, when it was abandoned. Rafael Foguet also patented Abaperidone.
Source: Wikipedia "Omiloxetine" · CC BY-SA 4.0
Share this article: X · Bluesky